您当前的位置:
首页 >
文章列表页 >
C1 biotechnology: paradigm shift, strategic choice, and China’s mission
Perspective | 更新时间:2026-07-03
    • C1 biotechnology: paradigm shift, strategic choice, and China’s mission

    • Synthetic Biology Journal   Vol. 7, Issue 3, Pages: 491-494(2026)
    • DOI:10.12211/2096-8280.2026-014    

      CLC: Q81
    • Received:06 March 2026,

      Revised:2026-03-30,

      Published:30 June 2026

    移动端阅览

  • LI Yin. C1 biotechnology: paradigm shift, strategic choice, and China’s mission[J]. Synthetic Biology Journal, 2026, 7(3): 491-494 DOI: 10.12211/2096-8280.2026-014. DOI:

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

65

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Progress in microalgae chloroplast organelle factory development
Plant synthetic biology for carbon peak and carbon neutrality
Challenges and opportunities in the research of Synechococcus chassis under the context of carbon peak and neutrality
Research progress in carbon neutrality oriented adaptive laboratory evolution of microalgae
Progress in hybrid systems of biological entities and materials for low-carbon biosynthesis

Related Author

LI Yin
CAO Xupeng
WANG Wangyin
JIANG Jing
TIAN Jing
ZHU Zhen
ZHU Xinguang
YANG Jianzhao

Related Institution

School of Chemical and Materials Science, University of Science and Technology of China
School of Bioengineering, Dalian Polytechnic University
China State Key Laboratory of Catalysis, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian National Laboratory for Clean Energy
University of Chinese Academy of Sciences
National Key Laboratory of Plant Molecular Genetics, CAS Center for Excellence in Molecular Plant Sciences, Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences
0